How Much is Semaglutide for Achieving Medical Weight Loss?

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to treat type 2 diabetes, but clinical evidence has shown its powerful effects on appetite suppression and weight reduction. The cost of semaglutide for weight loss varies by delivery method and treatment plan, but PlexusDx offers transparent, flat monthly pricing with no surprise fees. Understanding your options helps you choose the right approach for your health goals.

What Does Semaglutide Cost Per Month?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across flexible commitment tiers. This flat-rate pricing means your monthly cost remains stable regardless of dose adjustments—your dose may need to go up, but your price won't. The medication comes from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility without the markup of brand-name options.

For patients who prefer oral delivery, PlexusDx offers oral semaglutide at $289/mo month-to-month, or from $249/mo on the 6-month plan. Both injection and oral formats are available to all 50 states without requiring health insurance, and both qualify as HSA and FSA eligible expenses. The choice between injection and oral depends on your preference, absorption tolerance, and clinical response tracking with your PlexusDx provider.

How Does Compounded Semaglutide Compare to Brand-Name Options?

Brand-name semaglutide (Wegovy for weight loss, Ozempic for diabetes) typically costs $900–$1,500 per month without insurance, and many plans do not cover weight loss use. Compounded semaglutide from licensed 503A pharmacies delivers the same active pharmaceutical ingredient at a fraction of that cost, making medical weight loss accessible to a broader population. PlexusDx pricing reflects the efficiency of compounding without compromising quality or potency.

Compounded medications are not FDA-approved as finished products, but the ingredient sourcing and preparation follow strict United States Pharmacopeia (USP) standards and state pharmacy board regulations. PlexusDx partners exclusively with licensed 503A compounding pharmacies—never 503B bulk manufacturers—to ensure personalized, patient-specific preparation. This model has become standard in precision medicine and allows for faster access and lower costs compared to manufactured pharmaceuticals.

What Factors Influence Your Total Weight Loss Investment?

Your actual cost of semaglutide therapy depends on several variables: the starting dose, how quickly your provider increases your dose during the titration phase, how long you remain on treatment, and whether you add genetic testing for personalization. Most patients begin at low doses (0.25 mg weekly) and advance over 4–8 weeks to maintenance doses (0.5–2.4 mg weekly). PlexusDx flat monthly pricing means you budget the same amount whether you are at the starting dose or maintenance dose.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Is Semaglutide Affordable Without Insurance?

Yes. PlexusDx serves all 50 states and requires no health insurance, no membership fee, and no annual enrollment. The flat monthly pricing model ($189 for semaglutide injection) makes weight loss treatment predictable and budget-friendly for self-pay patients. Many people find that even without insurance coverage, compounded semaglutide costs less than a single month of brand-name alternatives, and savings compound over a year of treatment.

Both semaglutide injection and oral semaglutide are eligible for Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA), which can further reduce your out-of-pocket expense if you have either account. PlexusDx billing is straightforward: one price per month, no hidden dose tiers, and no surprise invoices. If you have questions about payment plans or financial assistance, PlexusDx customer support can discuss options tailored to your situation.

What Results Can You Expect at This Price Point?

Clinical trials of semaglutide for weight loss (STEP 1–4) demonstrated average weight reductions of 10–22% over 68 weeks, with many patients losing 20+ pounds and improving metabolic markers like blood pressure and blood sugar. Real-world outcomes with compounded semaglutide are comparable to brand-name formulations when dosed appropriately and paired with lifestyle support. The low cost does not reflect lower efficacy—it reflects more efficient manufacturing and direct-to-patient access.

Individual results vary based on genetics, adherence, diet, exercise, and baseline metabolic health. PlexusDx uses the Precision Peptide Genetic Test to identify which patients are most likely to respond robustly to semaglutide monotherapy versus those who may benefit from dual-compound therapy (GLP-Squared, combining semaglutide and tirzepatide). This personalized approach helps maximize your investment by matching you to the treatment most likely to work for your unique biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Does the $149 per month price for semaglutide injection include doctor visits and follow-up care?

The $189 monthly price covers the compounded medication only. PlexusDx coordinates with licensed practitioners for prescribing, dose adjustments, and monitoring, but telehealth consultation fees may apply separately depending on your plan. PlexusDx can provide details on total care costs when you schedule your initial assessment.

How much weight can I expect to lose with semaglutide in three months?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I use my HSA or FSA to pay for semaglutide through PlexusDx?

Yes. Both compounded semaglutide injection ($189/month) and oral semaglutide ($289/month) are eligible expenses for HSA and FSA accounts. Using these pre-tax accounts can effectively reduce your monthly cost by 20–37% depending on your tax bracket. Check with your HSA/FSA plan administrator or provide PlexusDx with your account details during checkout.

What side effects should I expect, and do they justify the cost?

Common side effects include nausea, constipation, and appetite loss—most mild and transient during dose escalation. Serious adverse events are rare when dosed appropriately. The $149 monthly cost is substantially lower than emergency care for weight-related complications (diabetes, heart disease, joint damage), making semaglutide a cost-effective investment in long-term health prevention.

Does my genetic test result change how much semaglutide costs?

No. The Precision Peptide Genetic Test ($298) identifies your genetic predispositions to GLP-1 sensitivity and other metabolic pathways but does not affect medication pricing. Whether you carry favorable GLP1R variants or variants linked to weaker response, your semaglutide injection remains $189 per month—the test just helps your provider personalize your regimen for best outcomes.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.